Detalhe da pesquisa
1.
MRD dynamics during maintenance for improved prognostication of 1280 patients with myeloma in the TOURMALINE-MM3 and -MM4 trials.
Blood;
141(6): 579-591, 2023 02 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36130300